Discontinued — last reported Q2 '24

Current Liabilities

Accrued Manufacturing Costs

GE HealthCare Technologies Accrued Manufacturing Costs decreased by 14.9% to $1.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $1.34B to $1.42B. Over 2 years (FY 2023 to FY 2025), Accrued Manufacturing Costs shows relatively stable performance with a 4.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ2 2024
Metric ID: accrued_manufacturing_costs

Historical Data

9 periods
 Q4 '23Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.52B$1.24B$1.42B$1.52B$1.34B$1.36B$1.54B$1.67B$1.42B
QoQ Change-18.6%+15.1%+7.0%-11.7%+1.6%+13.0%+8.0%-14.9%
YoY Change+0.2%+10.4%+8.4%+9.5%+5.6%
Range$1.24B$1.67B
CAGR-3.3%
Avg YoY Growth+6.8%
Median YoY Growth+8.4%

Accrued Manufacturing Costs at Other Companies

Frequently Asked Questions

What is GE HealthCare Technologies's accrued manufacturing costs?
GE HealthCare Technologies (GEHC) reported accrued manufacturing costs of $1.42B in Q1 2026.
How has GE HealthCare Technologies's accrued manufacturing costs changed year-over-year?
GE HealthCare Technologies's accrued manufacturing costs increased by 5.6% year-over-year, from $1.34B to $1.42B.
What is the long-term trend for GE HealthCare Technologies's accrued manufacturing costs?
Over 2 years (2023 to 2025), GE HealthCare Technologies's accrued manufacturing costs has grown at a 4.8% compound annual growth rate (CAGR), from $1.52B to $1.67B.